Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Acta Neuropathologica Communications|February 5, 2023
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomasSandra Ferreyra Vega, Thomas Olsson Bontell, Teresia Kling, et al.
Neuro-Oncology|January 23, 2019
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classificationAnna Wenger, Sandra Ferreyra Vega, Teresia Kling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2022
Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomasSandra Ferreyra Vega, Anna Wenger, Teresia Kling, et al.
Clinical Epigenetics|May 4, 2021
DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomasSandra Ferreyra Vega, Thomas Olsson Bontell, Alba Corell, et al.
Acta Neuropathologica Communications|July 16, 2022
DNA methylation alterations across time and space in paediatric brain tumoursAnna Wenger, Sandra Ferreyra Vega, Elizabeth Schepke, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2024
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classificationTeresia Kling, Sandra Ferreyra Vega, Medha Suman, et al.
BMC Cancer|May 22, 2020
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based studyAlba Corell, Sandra Ferreyra Vega, Nickoleta Hoefling, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Frontiers in Oncology|January 27, 2022
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasLouise Carstam, Alba Corell, Anja Smits, et al.
Pageof 2